Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$97,484,438
+$42,917,893 QoQ
Shares Held
1,791,664
+40.8% QoQ
Ownership
0.723%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#30
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,452,939 across 178 Biotechnology names. EXEL ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,484,438 | 1,791,664 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $54,566,545 | 1,272,244 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $59,669,767 | 1,361,391 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $58,468,616 | 1,415,705 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $49,212,498 | 1,116,436 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $22,248,545 | 602,615 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,848,304 | 415,865 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $12,030,809 | 463,615 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,886,889 | 440,004 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $10,485,147 | 441,852 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,575,516 | 190,726 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,810,969 | 1,410,113 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $20,487,678 | 1,072,092 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,711,068 | 1,324,630 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $17,443,195 | 1,087,481 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,784,350 | 1,134,206 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $51,633,121 | 2,479,977 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $38,680,574 | 1,706,245 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $935,113 | 51,155 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $16,094,579 | 761,333 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $25,263,232 | 1,386,566 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $1,126,856 | 49,883 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $328,505 | 16,368 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $13,131,997 | 537,096 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,066,614 | 466,159 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,353,422 | 194,740 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||